Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Sep;11(9):2268-2276.
doi: 10.1002/acn3.52127. Epub 2024 Aug 30.

Expert panel curation of 31 genes in relation to limb girdle muscular dystrophy

Affiliations

Expert panel curation of 31 genes in relation to limb girdle muscular dystrophy

Shruthi Mohan et al. Ann Clin Transl Neurol. 2024 Sep.

Abstract

Objective: Limb girdle muscular dystrophies (LGMDs) are a group of genetically heterogeneous autosomal conditions with some degree of phenotypic homogeneity. LGMD is defined as having onset >2 years of age with progressive proximal weakness, elevated serum creatine kinase levels and dystrophic features on muscle biopsy. Advances in massively parallel sequencing have led to a surge in genes linked to LGMD.

Methods: The ClinGen Muscular Dystrophies and Myopathies gene curation expert panel (MDM GCEP, formerly Limb Girdle Muscular Dystrophy GCEP) convened to evaluate the strength of evidence supporting gene-disease relationships (GDR) using the ClinGen gene-disease clinical validity framework to evaluate 31 genes implicated in LGMD.

Results: The GDR was exclusively LGMD for 17 genes, whereas an additional 14 genes were related to a broader phenotype encompassing congenital weakness. Four genes (CAPN3, COL6A1, COL6A2, and COL6A3) were split into two separate disease entities, based on each displaying both dominant and recessive inheritance patterns, resulting in curation of 35 GDRs. Of these, 30 (86%) were classified as definitive, 4 (11%) as moderate, and 1 (3%) as limited. Two genes, POMGNT1 and DAG1, though definitively related to myopathy, currently have insufficient evidence to support a relationship specifically with LGMD.

Interpretation: The expert-reviewed assertions on the clinical validity of genes implicated in LGMDs form an invaluable resource for clinicians and molecular geneticists. We encourage the global neuromuscular community to publish case-level data that help clarify disputed or novel LGMD associations.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Curation classifications of the 35 gene–disease relationships curated by the MDM GCEP. Genetic and experimental evidence scores of the 35 gene–disease relationships. POMGNT1 and DAG1, though definitively related to myopathy, currently have insufficient evidence to support a relationship specifically with LGMD and are noted in red. *denote genes co‐curated by the congenital myopathy and MDM GCEP.
Figure 2
Figure 2
Mondo revision recommended by the MDM GCEP for the muscular dystrophy‐dystroglycanopathy genes. (A) Previous parent (+) and child (−) terms for α‐dystroglycanopathy genes. (B) Proposed parent and child terms for α‐dystroglycanopathy genes.

Update of

References

    1. Nigro V, Savarese M. Genetic basis of limb‐girdle muscular dystrophies: the 2014 update. Acta Myol. 2014;33(1):1‐12. - PMC - PubMed
    1. Strafella C, Campoli G, Galota RM, et al. Limb‐girdle muscular dystrophies (LGMDs): the clinical application of NGS analysis, a family case report. Front Neurol. 2019;10:619. - PMC - PubMed
    1. Angelini C. LGMD. Identification, description and classification. Acta Myol. 2020;39(4):207‐217. - PMC - PubMed
    1. Georganopoulou DG, Moisiadis VG, Malik FA, et al. A journey with LGMD: from protein abnormalities to patient impact. Protein J. 2021;40(4):466‐488. - PMC - PubMed
    1. Straub V, Murphy A, Udd B, LGMD Workshop Study Group . 229th ENMC International Workshop: limb girdle muscular dystrophies—nomenclature and reformed classification Naarden, The Netherlands, 17–19 March 2017. Neuromuscul Disord. 2018;28(8):702‐710. - PubMed

LinkOut - more resources